Silo pharma submits application for nasdaq up-listing

Englewood cliffs, nj, may 25, 2021 (globe newswire) -- silo pharma, inc. (otcqb: silo) a development stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, is pleased to announce that it has submitted its initial application to list on the nasdaq capital market (“nasdaq”).

SILO Ratings Summary

SILO Quant Ranking